ARISTO BIO-TECH AN (ARISTO-SM.NS)
INR 160.0
(0.0%)
INR 160.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 76 Million | -27.83 Million | 67.78 Million | 22.84 Million | 14.07 Million | 81.48 Million |
| Net Income | 38.95 Million | 35.62 Million | 14.33 Million | 10.75 Million | 10.07 Million | 28.28 Million |
| Depreciation & Amortization | 15.7 Million | 15.36 Million | 10.98 Million | 7.49 Million | 5.19 Million | 5.06 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -236.22 Million | -207.58 Million | 48.48 Million | -26.3 Million | 216.91 Million | -18.68 Million |
| Other non-cash items | 257.56 Million | 128.76 Million | -6.02 Million | 30.9 Million | -218.1 Million | 66.82 Million |
| Investing Cash Flow | -66.09 Million | -37.45 Million | -31.6 Million | -19.77 Million | -21.92 Million | -24.4 Million |
| Investments in PPE | -65.54 Million | -40.6 Million | -32.48 Million | -19.89 Million | -22 Million | -20.83 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -547 Thousand | 3.14 Million | 887 Thousand | 115 Thousand | 80 Thousand | -3.57 Million |
| Financing Cash Flow | -22.06 Million | 79.65 Million | -33.13 Million | -7.19 Million | 8.72 Million | -57.69 Million |
| Debt repayment | -1.69 Million | -9.25 Million | -9.68 Million | -13.89 Million | -34.73 Million | -35.21 Million |
| Dividends payments | -4.42 Million | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -15.94 Million | 88.9 Million | -23.44 Million | -21.08 Million | -26 Million | -22.48 Million |
| Accounts receivables | -128.99 Million | -113.72 Million | -4.34 Million | 155.4 Million | -60.41 Million | 60.95 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -94.09 Million | -64.15 Million | 75.83 Million | -76.21 Million | 86.63 Million | -40.93 Million |
| Other working capital | -13.13 Million | -29.7 Million | -23 Million | -105.49 Million | 190.69 Million | -38.7 Million |
| Cash at beginning of period | 18.52 Million | 4.16 Million | 1.12 Million | 5.25 Million | 4.37 Million | 4.99 Million |
| Cash at end of period | 6.37 Million | 18.52 Million | 4.16 Million | 1.12 Million | 5.25 Million | 4.37 Million |
| Capital Expenditure | -65.54 Million | -40.6 Million | -32.48 Million | -19.89 Million | -22 Million | -20.83 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -12.15 Million | 14.36 Million | 3.04 Million | -4.12 Million | 872 Thousand | -613 Thousand |
| Free Cash Flow | 10.45 Million | -68.44 Million | 35.29 Million | 2.94 Million | -7.93 Million | 60.65 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 38.95 Million | 6.61 Million | 6.61 Million | 12.86 Million | 12.86 Million | 35.62 Million |
| Depreciation & Amortization | 15.7 Million | 3.97 Million | 3.97 Million | 3.87 Million | 3.87 Million | 15.36 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -236.22 Million | 8.86 Million | 8.86 Million | -126.98 Million | -126.98 Million | -207.58 Million |
| Other non-cash items | 257.56 Million | 3.17 Million | 3.17 Million | 125.6 Million | 125.6 Million | 128.76 Million |
| Investing Cash Flow | -66.09 Million | -20.25 Million | -20.25 Million | -12.79 Million | -12.79 Million | -37.45 Million |
| Investments in PPE | -65.54 Million | -19.83 Million | -19.83 Million | -12.94 Million | -12.94 Million | -40.6 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -546 Thousand | -423.5 Thousand | -423 Thousand | 150 Thousand | 150 Thousand | 3.14 Million |
| Financing Cash Flow | -22.06 Million | -2.83 Million | -2.83 Million | -8.19 Million | -8.19 Million | 79.65 Million |
| Debt repayment | -1.69 Million | - | - | - | - | -9.25 Million |
| Dividends payments | -4.42 Million | -1.36 Million | -1.36 Million | -851 Thousand | -851 Thousand | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -15.94 Million | -1.47 Million | -1.47 Million | -7.34 Million | -7.34 Million | 88.9 Million |
| Accounts receivables | -128.99 Million | 89.17 Million | 89.17 Million | -153.67 Million | -153.67 Million | -113.72 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -94.09 Million | -53 Million | -53 Million | 5.95 Million | 5.95 Million | -64.15 Million |
| Other working capital | -13.13 Million | -27.3 Million | -27.3 Million | 20.73 Million | 20.73 Million | -29.7 Million |
| Cash at beginning of period | 18.52 Million | -500.00 | - | - | - | 4.16 Million |
| Cash at end of period | 6.37 Million | -458.5 Thousand | -458.5 Thousand | -5.62 Million | -5.62 Million | 18.52 Million |
| Capital Expenditure | -65.54 Million | -19.83 Million | -19.83 Million | -12.94 Million | -12.94 Million | -40.6 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -12.15 Million | -458 Thousand | -458.5 Thousand | -5.62 Million | -5.62 Million | 14.36 Million |
| Free Cash Flow | 10.45 Million | 2.8 Million | 2.8 Million | 2.42 Million | 2.42 Million | -68.44 Million |
0953
GCFFF
0737
CO3A
BONTQ
HGSB